In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Akero Therapeutics Inc (NASDAQ: AKRO) closed at $56.41 in the last session, up 4.75% from day before closing price of $53.85. In other words, the price has increased by $4.75 from its previous closing price. On the day, 1.28 million shares were traded.
Ratios:
We take a closer look at AKRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 27 ’25 when Yale Catriona sold 53,590 shares for $56.25 per share. The transaction valued at 3,014,216 led to the insider holds 95,648 shares of the business.
Yale Catriona sold 49,074 shares of AKRO for $2,734,212 on Jan 27 ’25. The Chief Development Officer now owns 95,648 shares after completing the transaction at $55.72 per share. On Jan 27 ’25, another insider, Rolph Timothy, who serves as the Chief Scientific Officer of the company, sold 31,250 shares for $55.77 each. As a result, the insider received 1,742,958 and left with 170,237 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $15.32. The 50-Day Moving Average of the stock is 76.30%, while the 200-Day Moving Average is calculated to be 108.28%.
Shares Statistics:
A total of 69.61M shares are outstanding, with a floating share count of 62.71M. Insiders hold about 16.53% of the company’s shares, while institutions hold 90.93% stake in the company.